| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Laboratory of Inorganic Chemistry, ETH Hönggerberg–HCI, Zürich, Switzerland
2 Scuola Internazionale Superiore di Studi Avanzati and INFM–DEMOCRITOS National Simulation Center, Trieste, Italy
Reprint requests to: Professor Paolo Carloni, International School for Advanced Studies, via Beirut 4,34014, Trieste, Italy; e-mail: carloni{at}sissa.it; fax: +39-040-3787-528
The emergence of drug-resistant variants is a serious side effect associated with acquired immune deficiency syndrome therapies based on inhibition of human immunodeficiency virus type 1 protease (HIV-1 PR). In these variants, compensatory mutations, usually located far from the active site, are able to affect the enzymatic activity via molecular mechanisms that have been related to differences in the conformational flexibility, although the detailed mechanistic aspects have not been clarified so far. Here, we perform multinanosecond molecular dynamics simulations on L63P HIV-1 PR, corresponding to the wild type, and one of its most frequently occurring compensatory mutations, M46I, complexed with the substrate and an enzymatic intermediate. The quality of the calculations is established by comparison with the available nuclear magnetic resonance data. Our calculations indicate that the dynamical fluctuations of the mutated enzyme differ from those in the wild type. These differences in the dynamic properties of the adducts with the substrate and with the gem-diol intermediate might be directly related to variations in the enzymatic activity and therefore offer an explanation of the observed changes in catalytic rate between wild type and mutated enzyme. We anticipate that this "flexibility-assisted" mechanism might be effective in the vast majority of compensatory mutations, which do not change the electrostatic properties of the enzyme.
Keywords: HIV-1 protease; molecular dynamics; protein flexibility; compensatory mutations; drug resistance
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Trylska, V. Tozzini, C.-e. A. Chang, and J. A. McCammon HIV-1 Protease Substrate Binding and Product Release Pathways Explored with Coarse-Grained Molecular Dynamics Biophys. J., June 15, 2007; 92(12): 4179 - 4187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Siehl, L. A. Castle, R. Gorton, and R. J. Keenan The Molecular Basis of Glyphosate Resistance by an Optimized Microbial Acetyltransferase J. Biol. Chem., April 13, 2007; 282(15): 11446 - 11455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Hornak, A. Okur, R. C. Rizzo, and C. Simmerling HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations PNAS, January 24, 2006; 103(4): 915 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Tomatis, R. M. Rasia, L. Segovia, and A. J. Vila From the Cover: Mimicking natural evolution in metallo-{beta}-lactamases through second-shell ligand mutations PNAS, September 27, 2005; 102(39): 13761 - 13766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wittayanarakul, O. Aruksakunwong, S. Saen-oon, W. Chantratita, V. Parasuk, P. Sompornpisut, and S. Hannongbua Insights into Saquinavir Resistance in the G48V HIV-1 Protease: Quantum Calculations and Molecular Dynamic Simulations Biophys. J., February 1, 2005; 88(2): 867 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Perryman, J.-H. Lin, and J. A. McCammon HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs Protein Sci., April 1, 2004; 13(4): 1108 - 1123. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
